FOXQ1 Antibody, HRP conjugated

說明書

中文名稱：

FOXQ1兔多克隆抗體, HRP偶聯
貨號：

CSB-PA874860LB01HU
規格：

￥880
其他：

產品詳情
產品評價
相關產品
靶點詳情

產品詳情

產品名稱：

Rabbit anti-Homo sapiens (Human) FOXQ1 Polyclonal antibody
Uniprot No.：

Q9C009
基因名：

FOXQ1
別名：

Forkhead box protein Q1 antibody; Forkhead box Q1 antibody; FOX Q1 antibody; FOXQ 1 antibody; FOXQ1 antibody; FOXQ1_HUMAN antibody; Hepatocyte nuclear factor 3 forkhead antibody; Hepatocyte nuclear factor 3 forkhead homolog 1 antibody; HFH 1 antibody; HFH-1 antibody; HFH1 antibody; HNF 3/forkhead like protein 1 antibody; HNF-3/forkhead-like protein 1 antibody; HNF3/forkhead like protein 1 antibody; MGC77469 antibody; Q1 antibody; Winged helix / forkhead transcription factor antibody; Winged helix/forkhead transcription factor antibody; zgc:77469 antibody
宿主：

Rabbit
反應種屬：

Human
免疫原：

Recombinant Human Forkhead box protein Q1 protein (10-123AA)
免疫原種屬：

Homo sapiens (Human)
標記方式：

HRP
克隆類型：

Polyclonal
抗體亞型：

IgG
純化方式：

>95%, Protein G purified
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
產品提供形式：

Liquid
應用范圍：

ELISA
Protocols：

ELISA Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

功能：

Plays a role in hair follicle differentiation.
基因功能參考文獻：
1. inhibition of FOXQ1 restricted natural killer/T-cell lymphoma cell proliferation and growth but induced apoptosis PMID: 29132010
2. Findings indicate a positive feedback loop between cancer associated fibroblast (CAFs) and box Q1 (FOXQ1)/N-myc downstream-regulated gene 1 (NDRG1) axis in neoplastic cells to drive hepatocellular carcinoma (HCC) initiation, suggesting new potential therapeutic targets for HCC. PMID: 29248714
3. Results show that FOXQ1, a well-known oncogenic protein and promoter of gastric cancer (GC) metastasis, to be the direct downstream target of miR-345 in GC. Its mRNA and protein levels are up-regulated in GC tumors. PMID: 29048674
4. These data identify FOXQ1 as a melanoma suppressor. PMID: 28930679
5. Results revealed that, co-culture with TAMs promoted the invasion and migration of GC cells. Co-culture with TAMs induced EMT in GC cells. FOXQ1 is essential for TAM-induced EMT and metastasis in GC cells. PMID: 28791370
6. FOXQ1 remarkably inhibited the replicative senescence through depressing the expression of the inflammatory cytokines interleukin-6 (IL-6) and IL-8 via modulation of SIRT1-NF-kappaB pathway. PMID: 28726780
7. Cell viability and progression from G1 to S phase were both improved with overexpression of Foxq1, and microRNAs profiling study and dual-luciferase result suggested miR-320b contributed to the up-regulation of Foxq1 after calcium hydroxide stimulation. These results suggested that miR-320b mediated Foxq1 up-regulation promote proliferation of dental pulp stem cells. PMID: 29453987
8. We identified FOXM1 and FOXQ1 as novel prognostic biomarkers in colorectal cancer and miR-342 as a novel regulator of both FOXM1 and FOXQ1 PMID: 27162244
9. Data indicate a role for the miR-320/SOX4/FOXM1/FOXQ1 axes in promoting colorectal cancer (CRC) development and suggest targeting those networks as potential therapeutic strategy for CRC. PMID: 27119506
10. MiR-133 directly targeted and down-regulated FOXQ1 expression, which in turn reduced TGF-beta level. PMID: 26858166
11. There are several modes of regulation of FOXQ1 expression that have been demonstrated in normal and tumor cells, such as microRNA and the Wnt signaling pathway. The activation of FOXQ1 affects downstream genes promoting the initiation, proliferation and invasion, in addition to the metastasis of tumor cells PMID: 27176124
12. FOXQ1 is a prognostic marker for patients with Gastric cancer, FOXQ1 over-expression is involved in acquisition of the mesenchymal phenotype of gastric cancer cells, and subsequent Snail expression is essential for induction of Epithelial-Mesenchymal Transition. PMID: 27109028
13. The miR-506/FOXQ1 axis plays an important role in the pathogenesis of cervical cancer. PMID: 26935526
14. DATS administration inhibited ALDH1 activity in vivo in SUM159 xenografts. These results indicate that FoxQ1 is a novel target of bCSC inhibition by DATS. PMID: 27129776
15. Data suggest that forkhead box Q1 (FOXQ1) is a potential therapeutic target for the development of therapies for colorectal cancer. PMID: 25955104
16. we identified FOXQ1 as an oncogene to promote ESCC tumor cell proliferation and metastasis by negatively regulating CDH1 in esophageal squamous cell carcinoma cells PMID: 26349968
17. MiR-1271 inhibits cell proliferation, invasion, and epithelial-mesenchymal transition in gastric cancer by directly suppressing FOXQ1 expression. PMID: 26159618
18. Results demonstrate that miR-124 functions as a tumor-suppressive microRNA in nasopharyngeal carcinoma by repressing Foxq1 expression. PMID: 25098939
19. FoxQ1 expression is negatively associated with the overall survival of PC patients, and that this protein may therefore represent a novel molecular target and new prognostic biomarker for PC. PMID: 26122655
20. miR-506 functions as a tumor suppressor miRNA in nasopharyngeal carcinoma; its suppressive effects are mediated chiefly by repressing FOXQ1 expression. PMID: 25856555
21. NSCLC cells with silenced FoxQ1 had decreased cell proliferation, migration and invasion in cell culture and delayed growth of xenograft tumors in mice compared with corresponding control cells. PMID: 25356753
22. PDGFRalpha and beta can be directly regulated by Foxq1 or indirectly regulated through the Foxq1/Twist1 axis PMID: 25502837
23. The induction of EMT by FOXQ1 defines a new transfer function in promoting cancer behind possible mechanisms. PMID: 25287361
24. FOXQ1 expression is essential to maintain cell proliferation, motility/invasion, and epithelial-mesenchymal transition phenotypes in ovarian cancer cells. PMID: 23203039
25. critical role in the regulation of hepatocellular carcinoma development PMID: 25251503
26. Data indicate that knockdown of forkhead box Q1 protein FoxQ1 by its siRNA in cancer stem-like cells (CSLCs) resulted in the inhibition of aggressive behavior. PMID: 24719318
27. NAC1 is essential and sufficient for activation of FOXQ1 PMID: 24200849
28. FoxQ1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression. PMID: 24005989
29. High FoxQ1 expression is associated with hepatocarcinoma. PMID: 24211718
30. results show that FOXQ1 is a novel modulator of Twist1 expression and a regulator of colorectal cancer invasion and metastasis PMID: 23723077
31. Study demonstrates that an aggressive malignant phenotype of hepatocellular carcinoma is strongly linked to high FOXQ1 expression. PMID: 23623360
32. FOXQ1 expression level is an independent prognostic factor for the overall survival rate of gastric cancer patients. PMID: 23609035
33. Data show that FOXQ1 is one of the most over-expressed genes in CRC and a direct target of the canonical Wnt pathway. PMID: 23555880
34. FOXQ1 may be a novel epithelial-mesenchymal transition-inducing transcription factor through controlling the expression of E-cadherin. PMID: 23403865
35. FoxQ1 promotes glioma cell proliferation and migration by down-regulation of NRXN3 expression. PMID: 23383267
36. Increased levels of this transcription factor suggest a potential link with cell dysfunction induced by altered prelamin A metabolism. PMID: 22948034
37. this study showed that an interaction between FOXQ1 and SUMO1P1 for psychomotor speed. PMID: 22126837
38. Mechanistic investigations revealed that FOXQ1-induced EMT was associated with transcriptional inactivation of the epithelial regulator E-cadherin. Findings define a key role for FOXQ1 in regulating EMT and aggressiveness in human cancer. PMID: 21346143
39. Foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis. PMID: 21285253
40. FOXQ1 overexpression upregulated several genes that have positive roles for tumor growth of colorectal cancer. PMID: 20145154
41. Transforming growth factor-beta 2 is a transcriptional target for Akt/protein kinase B via this protein PMID: 12011061
42. This study demenostrated that the forkhead transcription factor is reduced in skeletal muscle of chronic spinal cord-injured patients. PMID: 19533653
顯示更多

收起更多
亞細胞定位：

Nucleus.
組織特異性：

Expressed predominantly in the stomach, trachea, bladder and salivary gland.
數據庫鏈接：

HGNC: 20951

OMIM: 612788

KEGG: hsa:94234

STRING: 9606.ENSP00000296839

UniGene: Hs.591352

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human